Recent years have seen a scramble to identify the genetic variance that predisposes or protects against certain cancers and the tumour gene signatures that could indicate which therapies will work and which won’t. A picture is now emerging of an infinitely complex field that is unlikely ever to live up to the high hopes of some scientists, but is certainly confounding the sceptics.
